Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

VRTX Vertex Pharmaceuticals Inc
$493.50 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy VRTX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 125.1B
Enterprise value 122.2B
Trailing PE 32.5829
Forward PE 22.835873
PEG Ratio 1.0146429385965
Enterprise to EBITDA 25.12
Enterprise to revenue 10.185
Price to book MRQ 6.792353
Price to sales TTM 10.566043

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-12-31
Revenue (TTM) 12.0B
EBITDA 5.2B
Diluted EPS TTM 15.32
Total Cash (MRQ) 6.6B
Current ratio (MRQ) 2.901
Operating Cash Flow (TTM) 3.6B

VRTX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent VRTX News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.